The core components of CRISPR-based genome-editing therapies are bacterial proteins called nucleases that can stimulate ...

If you're an investor searching for the next big market winners, Wall Street analysts have zeroed in on one biotech stock ...

Lehigh University bioenginering researcher Tomas Gonzalez-Fernandez recently secured funding through the National Science ...

Scribe announced its initial research collaboration with Sanofi for CRISPR-based cell therapies to address oncology ...

Ongoing launch of CASGEVY® continues to gain momentum--2025 is poised to be a catalyst-rich year with key updates across several ...

The new Express License service removes barriers to accessing this transformative gene editing technology for startups.An ...

Scribe Therapeutics, co-founded by Jennifer Doudna, is reducing staff, the latest layoffs among companies focused on CRISPR ...

Intellia expects to incur charges of $8m associated with the reorganisation, which will likely be incurred in Q1 2025.

Researchers at the Experimental and Clinical Research Center (ECRC), a joint institution of the Max Delbrück Center and ...

Imagine a world where the genetic code is as easy to edit as a simple copy-and-paste. This is the reality of CRISPR, a ...

What I've learned from my work in this field is that having a well-crafted commercial strategy is important for companies ...

CRISPR-Cas9 pioneer presented with National Medal of Technology and Innovation in White House awards ceremony.